Orbimed Advisors increased stake in X4 Pharmaceuticals, Inc. By Investing.com

© Reuters. Orbimed Advisors increased stake in X4 Pharmaceuticals, Inc.

On the 23rd of March, Orbimed Advisors bought 750 thousand X4 Pharmaceuticals, Inc. (NASDAQ:) shares for $7 million at an average price of $9.31 per share.
Shares of X4 Pharmaceuticals, Inc. are down -1.61% since the transaction.

Orbimed Advisors’s holding in X4 Pharmaceuticals, Inc. increased to about 1.8 million shares with the purchase.

Orbimed Advisors first bought X4 Pharmaceuticals, Inc. stock in the first quarter of 2019.

Other investors who also added to their X4 Pharmaceuticals, Inc. shares include Citigroup (NYSE:) and Squarepoint Ops.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.